Net income attributable to Intuitive Surgical, Inc. (1) Services revenue includes the effect of the following item: (2) Income from operations includes the effect of the following item: (3) Interest and other income, net includes the effect of the following item: Unrealized gains on strategic investments. As of December 31, 2019, Intuitive Surgical had an installed base of 5,582 da Vinci Surgical Systems, including 3,531 in the U.S., 977 in Europe, 780 in Asia, and 294 in the rest of the world . What To Expect From Intuitive Surgical's Q3? -- Trefis The Company shipped 336 da Vinci Surgical Systems in the third quarter of 2021, compared with 195 systems in the third quarter of 2020. ISRG Stock Price & Charts | Intuitive Surgical The tax effects of the non-GAAP items are determined by applying a calculated non-GAAP effective tax rate, which is commonly referred to as the with-and-without method. This book presents best selected papers presented at the International Conference on Paradigms of Computing, Communication and Data Sciences (PCCDS 2020), organized by National Institute of Technology, Kurukshetra, India, during 1-3 May ... Intuitive Surgical Inc. (ISRG) Q3 2020 Earnings Call Transcript October 16, 2020 March 9, 2021 Intuitive Surgical Inc (NASDAQ: ISRG) Q3 2020 earnings call dated Oct. 15, 2020 Corporate Participants: Philip Kim -- Head of Investor Relations Gary S. Is Intuitive Surgical (ISRG) a Smart Long-term Buy ... Intuitive's rebound from the pandemic's blow to non-emergency care in 2020 was picking up steam in the second quarter, enough so that the company felt comfortable bumping up its procedure outlook. Presents a multifaceted model of understanding, which is based on the premise that people can demonstrate understanding in a variety of ways. As of December 31, 2019, Intuitive Surgical had an installed base of 5,582 da Vinci Surgical Systems, including 3,531 in the U.S., 977 in Europe, 780 in Asia, and 294 in the rest of the world . Intuitive Surgical, Inc. (NASDAQ:ISRG) Q3 2020 Results Earnings Conference Call October 15, 2020 4:30 PM ET Company Participants Philip Kim - Head, Investor Relations Gary Guthart - Chief Executive Officer Marshall Mohr - Chief Financial Officer Conference … Intuitive Surgical Investor Relations News - Intuitive ... The Zacks Rank #4 (Sell) company reported revenues of $1.08 billion, which fell 4.5% from the prior-year quarter. The compound annual growth rate between the third quarter of 2019 and the third quarter of 2021 was 13%. Intuitive Surgical revenue breakdown by business segment: 53.8% from Instruments and Accessories, 30.1% from Systems and 16.2% from Services. Intuitive Surgical peak revenue was $4.5B in 2019. The Company defines non-GAAP gross profit as gross profit, excluding intangible asset charges, expenses related to SBC, and litigation charges and recoveries. conference date: October 19, 2021 @ 1:30 PM Pacific Time for quarter ending: September 30, 2021 (third quarter, Q3 2021) Forward-looking statements. Intuitive Surgical (ISRG) - Conference Call Transcripts Non-GAAP gross profit, non-GAAP income from operations, non-GAAP net income, and non-GAAP EPS exclude items such as intangible asset charges, re-measurement of contingent consideration, SBC, excess tax benefits or deficiencies associated with SBC arrangements, and non-cash amortization of deferred tax assets related to intra-entity transfer of non-inventory assets, which are primarily recurring items. Non-GAAP net income attributable to Intuitive Surgical, Inc. $ 434.7 $ 477.1 $ 333.8 $ 1,339.0 $ 788.9 GAAP net income per share attributable to Intuitive Surgical, Inc. - diluted $ 1.04 $ 1.42 . Intuitive Surgical ISRG. Using Intuitive's da Vinci system, robotic surgery procedures increased about 20% worldwide over the third quarter of 2020, with COVID-19 pandemic disruptions . Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Operator. Third quarter 2021 non-GAAP* net income was $435 million, or $1.19 per diluted share, compared with $334 million, or $0.92 per diluted share, in the third quarter of 2020. Third quarter 2021 instruments and accessories revenue increased by 20% to $755 million, compared with $631 million in the third quarter of 2020, primarily driven by approximately 20% growth in da Vinci procedure volume. In the second quarter of 2020, year-over-year . The stock price of Intuitive Surgical has seen a rise of around 3% over the last five tradings days after it announced its Q3 results, which were above the street estimates. Robotic Cardiac Surgery Shares of Intuitive Surgical (NASDAQ:ISRG) fell 1.75% after the company reported Q3 results.Quarterly Results Earnings per share fell 19.24% over the past year to $2.77, which beat the estimate of . What To Expect From Intuitive Surgical's Q3? The Company uses these non-GAAP financial measures for financial and operational decision-making and as a means to evaluate period-to-period comparisons. Sold -143 Thousand shares Q1 2020 Avg closing price $183.15 Price range . The Company undertakes no obligation to publicly update or release any revisions to these forward-looking statements, except as required by law. Act 3.48 Est 3.38 . October 19, 2021 14:45 ET Price range. This report will help you learn the historical net income (net profit) values of Intuitive Surgical Inc. You will see how the profit has grown over the years and quarters. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. This press release contains forward-looking statements. Q3 Estimates See insights on Intuitive Surgical including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Act 3.48 Est 3.38 . Intuitive Surgical (ISRG) 46 mins Reynolds Consumer Products Inc. (REYN) CEO Lance Mitchell on Q3 2021 Results - Earnings Call Transcript Seeking Alpha 1 hour ViewRay, Inc.'s . Intuitive Surgical revenue breakdown by geographic segment: 69.9% from U.S. and 30.1% from Outside of U.S. FY, 2019. | Source: The Company defines non-GAAP net income as net income (loss), excluding intangible asset charges, non-cash impairment charges and recoveries, certain acquisition-related items for the re-measurement of contingent consideration, expenses related to SBC, litigation charges and recoveries, unrealized gains on strategic investments, adjustments attributable to noncontrolling interest in joint venture, net of the related tax effects, and tax adjustments, including the excess tax benefits or deficiencies associated with SBC arrangements, the one-time impact of the enactment of the 2019 Swiss tax reform, and the net tax effects related to intra-entity transfers of non-inventory assets. Q3 procedure growth reflected 16% growth . To track all upcoming earnings announcements, click here to use Benzinga Earnings Calendar. Third quarter 2020 GAAP net income was $314 million, or $2.60 per diluted share, compared with $397 million, or $3.33 per diluted share, in the third quarter of 2019. Intuitive brings more than two decades of leadership in robotic-assisted surgical technology and solutions to its offerings and develops, manufactures, and markets the da Vinci Surgical System and the Ion endoluminal system. Laparoscopic surgery has demonstrated to have an important role among the different technique described to repair ventral hernia with less recurrent rate, less morbidity and less overall cost than open conventional repair, with all the ... The Company excludes a one-time tax benefit from re-measurement of certain deferred tax assets, because it is discrete in nature, and excludes the excess tax benefits or deficiencies associated with SBC arrangements as well as the tax effects associated with non-cash amortization of deferred tax assets related to intra-entity non-inventory transfers, because the Company does not believe these items correlate with the on-going results of its core operations. In the last reported quarter, the company delivered an earnings surprise of 24.1%. The non-GAAP* measures are described below and are reconciled to the corresponding GAAP measures at the end of this release. and Intuitive Surgical last week said it has . With the company scaling successfully, its profitability and overall margins have been moving higher by the quarter. Intuitive will hold a teleconference at 1:30 p.m. PDT today to discuss the third quarter 2020 financial results. Third quarter 2020 GAAP income from operations decreased to $270 million, compared with $366 million in the third quarter of 2019, primarily as a result of the significant impact caused by the COVID-19 pandemic and the effects of the Customer Relief Program.
Log in. These benefits are excluded from non-GAAP net income. Why NKLA Stock is Soaring Today. Found inside â Page 553The expansion of the da Vinci use to the pelvis, abdomen, and K. C. Kim (â)· C. K. Buffington Department of General ... compared to 169 in Q3 of 2017, and revenue grew from 14% to 921 million USD, according to Intuitive's investor ... The Company believes that these non-GAAP financial measures provide meaningful supplemental information regarding its performance and liquidity by excluding items such as intangible asset charges, share-based compensation (“SBC”) expenses, and other special items. The Company launched Intuitive Ventures, an inaugural $100 million fund focused on investment opportunities in companies that share Intuitive's commitment to advancing positive outcomes in healthcare. Due to the continued uncertainty around the scope and duration of the pandemic and the timing of global recovery and economic normalization, we cannot, at this time, reliably estimate the future impact on our operations and financial results.
Its earnings beat estimates in each of the trailing four quarters, the average surprise being 63.8%. Compared to Q3 2019, the compound average annual growth was only 12%, reflecting the year-over-year decline in 2020. INTUITIVE SURGICAL, INC. UNAUDITED QUARTERLY CONDENSED CONSOLIDATED STATEMENTS OF INCOME (IN MILLIONS, EXCEPT PER SHARE DATA) Three months ended September 30, 2020 June 30, 2020 September 30, 2019 . The Company uses these non-GAAP financial measures for financial and operational decision-making and as a means to evaluate period-to-period comparisons. Intuitive Surgical, Inc. SUNNYVALE, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended September 30, 2020. Stay up-to-date on all of the upcoming earnings reports by visiting Investing . For the last 17 years, Intuitive Surgical has had complete control over the $2.8 billion market because they are the only manufacturer of surgical robotic systems with a marketable product. Intuitive Surgical Inc (NASDAQ: ISRG) reported Q3 adjusted EPS of $1.19, slightly ahead of the consensus of $1.17. This book provides a trove of insightful perspectives on the current state and the realization of digital surgery. Without excluding these tax effects, investors would only see the gross effect that these non-GAAP adjustments had on the Company’s operating results. Thank you for subscribing! A daily collection of all things fintech, interesting developments and market updates. Over the last 52-week period, shares are up 32.43%. Here's what investors need to know before the announcement. Revenue was $1.40 billion, down 4% sequentially from $1.46 billion and up 30% from $1.08 billion in the year-earlier quarter. Non-GAAP gross profit. Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, California, is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. Intuitive Surgical, Inc. ISRG is scheduled to release third-quarter 2020 results on Oct 15, after the closing bell.In the last reported quarter, the Zacks Rank #3 (Hold) company delivered an . This book is a valuable tool to assist both cardiovascular physicians and scientists learning the intricacies of hypertension research and its milestone studies. Third quarter 2021 GAAP income from operations increased to $443 million, compared with $270 million in the third quarter of 2020. Third quarter 2020 GAAP net income was $314 million, or $2.60 per diluted share, compared with $397 million, or $3.33 per diluted share, in the third quarter of 2019. INTUITIVE SURGICAL, INC. UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (IN MILLIONS, EXCEPT PER SHARE DATA)* Three months ended Nine months ended September 30, 2021 June 30, 2021 September 30, 2020 September 30, 2021 September 30, 2020: GAAP gross profit $ 971.4 $ 1,023.7 $ 724.3 $ 2,897.7 $ 1,965.4 Share-based compensation . to growth of 7% during the third quarter of 2020. Q3 2017 Avg closing price $108.96 Price range $102.41 - $116.26. Now, Intuitive say the virus is stressing some hospitals and reducing demand for surgeries, at least in the third quarter. Fiscal Period: December 2019 Q2: 2019 Q3: 2019 Q4: 2020 Q1: 2020 Q2: 2020 Q3: 2020 Q4: 2021 Q1: 2021 Q2: 2021 Q3: 2021 Q4: 2022 Q1: 2022 Q2: 2022 Q3: 2022 Q4: Net . Increased shares by 23.7% . The third quarter of 2020 reflected significant disruption caused by the COVID-19 pandemic, and the third quarter of 2021 reflected a COVID-19 resurgence, which also significantly impacted our procedures. ET. This text assumes students have been exposed to intermediate algebra, and it focuses on the applications of statistical knowledge rather than the theory behind it. Third quarter 2020 revenue of $1,078 million decreased 4% compared with $1,128 million in the third quarter of 2019. (4) Income tax expense includes the effect of the following items: Accounts payable and other accrued liabilities, Total liabilities and stockholders’ equity, Adjustments attributable to noncontrolling interest in joint venture. There are a number of limitations related to the use of non-GAAP measures versus measures calculated in accordance with GAAP. Shares have added about 6.4% in that time frame, outperforming the S&P 500. It reported revenues of $1.403 billion, +30% Y/Y,. The stock hit a low of $360.50 in March 2020 as many surgical procedures were delayed because of the global pandemic. Non-GAAP income from operations. Additionally, in conjunction with the Company's 2020 COVID-19 Customer Relief Program, third quarter 2020 revenue was reduced by $23 million for service fee credits provided to customers. Written by highly respected surgeons, Pediatric Robotic Urology provides a state-of-the-art, comprehensive overview of the precise surgical techniques that are changing the practice of pediatric urologic surgery. Third quarter 2020 GAAP net income included excess tax benefits of $48 million, or $0.40 per share, compared with $29 million, or $0.24 per share, in the third quarter of 2019. Intuitive Surgical annual revenue for 2019 was $4.5B, a 20.25% growth from 2018. Third quarter 2020 non-GAAP* net income was $334 million, or $2.77 per diluted share, compared with $409 million, or $3.43 per diluted share, in the third quarter of 2019. (1) For the three months ended September 30, 2021, tax adjustments included: (a) excess tax benefits associated with share-based compensation arrangements of $(41.9) million, or $(0.12) per diluted share; (b) tax impact related to intra-entity transfers of non-inventory assets of $7.0 million, or $0.02 per diluted share; and (c) other tax adjustments effects determined by applying a calculated non-GAAP effective tax rate of $(30.2) million, or $(0.08) per diluted share. October 15, 2020 16:05 ET However, the results topped the Street view. Gross profit, income from operations, net income, net income per diluted share, and diluted shares are reported on a GAAP and non-GAAP* basis. There are a number of limitations related to the use of non-GAAP measures versus measures calculated in accordance with GAAP. These forward-looking statements should, therefore, be considered in light of various important factors, including, but not limited to, the following: our ability to obtain accurate procedure volume in the midst of the COVID-19 pandemic; the risk that the COVID-19 pandemic could lead to further material delays and cancellations of, or reduced demand for, procedures; curtailed or delayed capital spending by hospitals; disruption to our supply chain; closures of our facilities; delays in surgeon training; delays in gathering clinical evidence; the evaluation of the risks of robotic-assisted surgery in the presence of infectious diseases; diversion of management and other resources to respond to the COVID-19 outbreak; the impact of global and regional economic and credit market conditions on healthcare spending; the risk that the COVID-19 pandemic disrupts local economies and causes economies in our key markets to enter prolonged recessions; healthcare reform legislation in the U.S. and its impact on hospital spending, reimbursement, and fees levied on certain medical device revenues; changes in hospital admissions and actions by payers to limit or manage surgical procedures; the timing and success of product development and market acceptance of developed products; the results of any collaborations, in-licensing arrangements, joint ventures, strategic alliances, or partnerships, including the joint venture with Shanghai Fosun Pharmaceutical (Group) Co., Ltd.; our completion of and ability to successfully integrate acquisitions, including Schölly Fiberoptic's robotic endoscope business and Orpheus Medical; procedure counts; regulatory approvals, clearances, and restrictions or any dispute that may occur with any regulatory body; guidelines and recommendations in the healthcare and patient communities; intellectual property positions and litigation; competition in the medical device industry and in the specific markets of surgery in which we operate; risks associated with our operations outside of the United States; unanticipated manufacturing disruptions or the inability to meet demand for products; our reliance on sole and single source suppliers; the results of legal proceedings to which we are or may become a party; product liability and other litigation claims; adverse publicity regarding us and the safety of our products and adequacy of training; our ability to expand into foreign markets; the impact of changes to tax legislation, guidance, and interpretations; changes in tariffs, trade barriers, and regulatory requirements; and other risk factors. The Company shipped 195 da Vinci Surgical Systems, a decrease of 29% compared with 275 in the third quarter of 2019.
ISRG is set to give its latest quarterly earnings report on Tuesday, 2021-10-19. This book is composed of a selection of articles from The 2021 World Conference on Information Systems and Technologies (WorldCIST'21), held online between 30 and 31 of March and 1 and 2 of April 2021 at Hangra de Heroismo, Terceira Island, ... Intuitive Surgical (NASDAQ:ISRG) Q3 2020 Earnings Call Oct 15, 2020, 4:30 p.m. These forward-looking statements are necessarily estimates reflecting the best judgment of our management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. In the U.S., for example, while da Vinci procedures have recovered a significant portion of the pre-COVID-19 levels, the resurgence of COVID-19 in some states has had, and will likely continue to have, an adverse impact on the Company’s procedure volumes. (4) Income tax expense (benefit) includes the effect of the following items: Excess tax benefits related to share-based compensation arrangements, One-time tax benefit from re-measurement of certain deferred tax assets. Edit Profile. SUNNYVALE, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended September 30, 2020. Intuitive believes that minimally invasive care is life-enhancing care. The company has placed nearly 6,000 da Vinci systems in hospitals worldwide, with nearly 4,000 installations in the United States and a growing number in . Intuitive Surgical, Inc. (NASDAQ: ISRG) stock recovered over 1% on October 16 th, 2020 (as of 11:12 am GMT-4 ; Source: Google finance) post yesterday's fall after the company in the third . INTUITIVE at J.P. Morgan Healthcare Conference. Overview: Strong y/y growth.. This book provides a practical guide to current methods for profiling and interpreting genomic alterations in tumors. 14 Ken Fisher Intuitive Surgical Inc transactions Avg closing price. Q3 2020 Intuitive Surgical, Inc. Earnings Conference call 10/15/2020 04:30 PM (EDT) ISRG. So why the big stock advance? Less: net income (loss) attributable to noncontrolling interest in joint venture. Da Vinci® and Ion™ are trademarks or registered trademarks of Intuitive Surgical, Inc. For more information, please visit the Company’s website at www.intuitive.com.
The impact and timing of the COVID-19 pandemic on the Company's business differs by geography. Statements using words such as “estimates,” “projects,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “may,” “will,” “could,” “should,” “would,” “targeted,” and similar words and expressions are intended to identify forward-looking statements. The call will be webcast by Nasdaq OMX and can be accessed on Intuitive’s website at www.intuitive.com or by dialing (877) 692-8955 using the access code 4083020. Listen to Webcast. The Company ended the third quarter of 2020 with $6.4 billion in cash, cash equivalents, and investments, an increase of $287 million during the quarter, primarily driven by cash generated from operations. 2020 Intuitive Surgical Inc - - USD 2019 Intuitive Surgical Inc - . Let us now see a simple line graph displaying the quarterly revenue of INTUITIVE SURGICAL INC between 2008 and 2020. Officers with the Supreme Court police discover a shocking crime--an anonymous person has smuggled a dead baby into the Supreme Court building. Less: net income attributable to noncontrolling interest in joint venture. We hope you will enjoy reading this volume, the first one to reflect a one hundred percent online EUROCALL conference/Online Gathering. Intuitive Surgical has a Good Q2 [July 22, 2021 @ Seeking Alpha]. Intuitive, headquartered in Sunnyvale, California, is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. (1) For the three months ended September 30, 2020, tax adjustments included: (a) excess tax benefits associated with share-based compensation arrangements of $(47.9) million, or $(0.40) per diluted share; (b) tax impact related to intra-entity transfers of non-inventory assets of $11.3 million, or $0.09 per diluted share; and (c) other tax adjustments effects determined by applying a calculated non-GAAP effective tax rate of $(9.4) million, or $(0.08) per diluted share. In addition, the components of the costs that the Company excludes in its calculation of non-GAAP net income and non-GAAP EPS may differ from the components that its peer companies exclude when they report their results of operations. Here's a look at Intuitive Surgical's past performance and the resulting price change: Shares of Intuitive Surgical were trading at $331.5 as of October 15. This press release contains forward-looking statements. The Company defines non-GAAP income from operations as income from operations, excluding intangible asset charges, certain acquisition-related items for the re-measurement of contingent consideration, expenses related to SBC, and litigation charges and recoveries. MedSurg sales increased 9.4% in that same time, and Neurotechnology and Spine sales grew 7.3%. Third quarter 2021 GAAP net income included other income related to unrealized gains on strategic investments of $8 million, or $0.02 per diluted share, compared with $62 million, or $0.17 per diluted share, in the third quarter of 2020. Everything you need to know about the market - quick & easy. Management addresses these limitations by providing specific information regarding the GAAP amounts excluded from non-GAAP net income and non-GAAP EPS and evaluating non-GAAP net income and non-GAAP EPS together with net income (loss) and net income (loss) per share calculated in accordance with GAAP. Intuitive Surgical Inc.'s P/S ratio increased from Q4 2020 to Q1 2021 but then slightly decreased from Q1 2021 to Q2 2021 not reaching Q4 2020 level. Who killed United States Senator Frank Boudreau with an ice pick? Robotic Cardiac Surgery is a comprehensive guide to robotic/totally endoscopic cardiac surgery. The book is intended to provide in-depth information regarding the history of robotic surgical systems, their components and principles. Most Recent Quarter Revenue. Intuitive Surgical Inc. ( NASDAQ: ISRG) reported lower earnings and revenues for the third quarter of 2020, hurt by the coronavirus-related disruption. The Company defines non-GAAP net income as net income, excluding intangible asset charges, non-cash impairment charges and recoveries, certain acquisition-related items for the re-measurement of contingent consideration, expenses related to SBC, litigation charges and recoveries, unrealized gains on strategic investments, adjustments attributable to noncontrolling interest in joint venture, net of the related tax effects, and tax adjustments, including the excess tax benefits or deficiencies associated with SBC arrangements, a one-time tax benefit from re-measurement of certain deferred tax assets, and the net tax effects related to intra-entity transfers of non-inventory assets. From Q4 2019 through Q2 2020, ISRG's revenues declined along with earnings. 2019 Q3: 2019 Q4: 2020 Q1: 2020 Q2: 2020 Q3: 2020 Q4: 2021 Q1: 2021 Q2: 2021 Q3: 2021 Q4: 2022 Q1: 2022 Q2: 2022 Q3: Sales M $ Released Forecast Spread: 974 975-0,16%: 1 099 . Third quarter 2021 systems revenue increased by 55% to $415 million, compared with $268 million in the third quarter of 2020. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. . Intuitive Surgical's adjusted net income of $ 477 million in the second quarter of 2021 reflects a strong 3.6-fold increase from its figure of $ 132 million in the . Welcome to the Intuitive Q3 2021 earnings release conference call. (4) Income tax expense includes the effect of the following items: Discrete tax expense arising from the conclusion of a tax matter, Accounts payable and other accrued liabilities, Total liabilities and stockholders’ equity, Adjustments attributable to noncontrolling interest in joint venture. Intuitive Surgical (NSDQ:ISRG) isn't resting on its laurels when it comes to the surgical robotics field that it dominates.The Sunnyvale, Calif.-based company is seeking to stay competitive through technologies including computer-controlled navigated robotic catheters, contrast agents to improve imaging during procedures, and intelligent surgical interfaces. Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, California, is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. Analysts estimate that Intuitive Surgical will likely report an Earnings Per Share (EPS) of $1.17. Will the recent positive trend continue leading up to its next earnings release, or is Intuitive Surgical, Inc. due for a pullback? - Vision Sensors and Cameras.- Digital Neural Networks for New Media.- Retinal Implants for Blind Patients.- Silicon Brains.- Energy Harvesting and Chip Autonomy.- The Energy Crisis.- The Extreme-Technology Industry. How does money figure into a happy life? In The Geometry of Wealth, behavioral finance expert Brian Portnoy delivers an inspired answer, building on the critical distinction between being rich and being wealthy. Intuitive Surgical up on mixed bag Q3 October 16, 2020 By Sean Whooley Intuitive Surgical (NSDQ: ISRG ) shares ticked slightly up today on third-quarter results that were mixed compared to the .